Albiet aerosolized delivery will likely avoid many of the systemic side effects of parenteral IFN-γ, our findings of upregulation of IFN-γ signaling in the macrophages and selected lymphoid populations of advanced IPF warrant caution in further augmenting this pathway. The gene discussed is IFNG; the disease is idiopathic pulmonary fibrosis.